Related Experiment Videos
Glucocorticoid receptors in human airways
L Pujols1, J Mullol, A Torrego
1Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Allergy
|September 10, 2004
Summary
Glucocorticoid receptor (GR) alpha and beta isoforms regulate respiratory disease treatments. While GRalpha is key, GRbeta
Area of Science:
- Pharmacology
- Molecular Biology
- Respiratory Medicine
Background:
- Inhaled and intranasal glucocorticoids are primary treatments for asthma, allergic rhinitis, and nasal polyposis.
- Understanding glucocorticoid receptor (GR) mechanisms is crucial for optimizing therapy.
- GRalpha mediates therapeutic effects, while GRbeta's role is debated.
Purpose of the Study:
- To provide an updated review of the GR gene, its isoforms (GRalpha and GRbeta), and their regulation.
- To examine alterations in GR expression in pathological states.
- To discuss the potential role of GRbeta in glucocorticoid sensitivity and resistance.
Main Methods:
- Literature review and synthesis of current research on GR gene expression and function.
- Analysis of GRalpha and GRbeta roles in target gene regulation.
- Examination of GRbeta expression in relation to glucocorticoid resistance in diseases.
Main Results:
- GRalpha is ubiquitously expressed and mediates glucocorticoid effects, with its expression downregulated by glucocorticoids.
- GRbeta acts as a dominant-negative inhibitor of GRalpha transactivation in vitro but has minimal impact on transrepression.
- GRbeta expression is low but can be upregulated by pro-inflammatory cytokines and is increased in conditions of glucocorticoid resistance.
Conclusions:
- GRalpha is the primary mediator of glucocorticoid action.
- GRbeta's role in modulating in vivo glucocorticoid sensitivity or resistance remains unclear and debated.
- Further research is needed to elucidate GRbeta's precise function in respiratory diseases and glucocorticoid response.